Purchase of Shares by PDMR

RNS Number : 5719G

The MedicX Fund Limited

30 May 2017

 

For immediate release

30 May 2017

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Purchase of Shares by PDMR

The Company announces that it has received notification that on 30 May 2017, Helen Mahy, Director and a PDMR of the Company purchased 28,604 ordinary shares in the Company.

The following notifications, which have been made in accordance with the requirements of the EU Market Abuse Regulations, provide further detail:

1.	Details of PDMR
a)	Name	Helen Mahy
2.	Reason for Notification Purchase of shares within an ISA
a)	Position/status	Director
b)	Initial notification/ amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MedicX Fund Limited
b)	LEI	2138008POF35FTNFCB25
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary shares of no par value GG00B1DVQL92
b)	Nature of the transaction	Purchase of 28,604 shares within an ISA.
c)	Price(s) and volume(s)	Price(s) Volume(s) 90.378p 28,604
d)	Aggregated Information	N/A single transaction
e)	Date of the transaction	30 May 2017
f)	Place of the transaction	London Stock Exchange, Main Market (XLON)
g)	Other information	Following the transaction, Helen Mahy holds 28,604 shares in the Company

End

For further information please contact:

MedicX Fund                                                                  [phone]

David Staples, Chairman

Octopus Healthcare Group                                               [phone]

Mike Adams, Chief Executive Officer

Buchanan                                                                        [phone]

Charles Ryland/Victoria Hayns

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", "the Fund" or "the Company", or together with its subsidiaries, "the Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 157 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £6 billion of funds for more than 50,000 retail and institutional investors.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement. 

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.

 

END

 

 

DSHBBLFXDEFZBBQ